Title: Incorporating the concept of atrial fibrillation (AF) burden into clinical practice

Commercial Supporters
Organized by Translational Medicine Academy (TMA), Basel, Switzerland, and supported by an independent educational grant from Pfizer.

Program Description
Atrial fibrillation (AF) poses a significant burden to patients, physicians, and healthcare systems globally. The concept of "AF burden" emerged as an innovative approach to make sense of the amount of data generated by the "digital revolution" in AF diagnosis. The goal of this program is to better understand the current and future definitions of AF burden, how to measure it, and how to use this concept in clinical practice in association with other risk stratification tools.

Intended Audiences
This activity is intended to meet the educational needs of a multidisciplinary group of care providers including cardiologists, internal medicine specialists, electrophysiologists, nurses and healthcare professionals involved in the care of patients with atrial fibrillation

Participants receive a 50 USD VISA gift card upon completion of the learning activity

Educational Learning Objectives

• Review the rationale for assessing atrial fibrillation (AF) burden with a risk-stratification approach
• Discuss the clinical utility of the various technologies for the detection and monitoring of AF burden
• Review the current definition of AF burden, its relevance in clinical practice, and its limitations
• Discuss how the concept of AF burden translates into clinical practice, particularly regarding the identification and management of patients at risk of stroke

Course Faculty

Professor Giuseppe Boriani, MD, PhD, FEHRA, FESC
Doctor of Philosophy (PhD) in Cardiovascular Physiopathology at the University of Milan, Italy.
Professor of Cardiology at the University of Modena and Reggio Emilia and Chief of Cardiology at Modena University Hospital.
Director of the Post-Graduate School of Cardiovascular Diseases at the University of Modena and Reggio Emilia.

Rod Passman, MD
Jules J. Reingold Professor of Electrophysiology at Northwestern University, Feinberg School of Medicine (USA).

Wolfram Doehner, MD, PhD, FESC, FHFA
Professor of Interdisciplinary Stroke Research at the Charité - Universitätsmedizin Berlin, Germany.

Faculty Disclosures:

Wolfram Doehner, MD, PhD, FESC, FHFA

• Research support: EU-FP7, HORIZON-2020, German Ministry of Education and Research,  German Center of Cardiovascular Research, Vifor Pharma, ZS Pharma
• Consulting and speaker honoraria: AiMediq, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Ferrer, Lilly, Medtronic, Pfizer, Sanofi, Sphingotec, Vifor Pharma.

Giuseppe Boriani, MD, PhD, FEHRA, FESC

• Consulting and speaker honoraria: Bayer, Boehringer Ingelheim, Boston Scientific, Daiichi Sankyo, Janssen, Sanofi.

Rod Passman, MD

• Consulting and speaker honoraria: Janssen Pharmaceuticals, Inc., John Wiley & Sons, Inc., Johnson & Johnson, Medtronic, Inc., Wolters Kluwer Health, Inc. (Wolters Kluwer NV), Wolters Kluwer NV

Disclosure of Financial Relationships Policy

Disclosure of Unlabeled Use

Disclaimer